AI – Medxy AI

AI vs. Human Clinicians: Study Reveals Gaps in AI-Generated Clinical Notes

By MedXY 04/21/2026

A cross-sectional evaluation of AI-generated clinical notes found significant quality deficits compared to human-produced notes, particularly in thoroughness, organization, and usefulness.

AI Cardiology news

Adaptive AI Transforms Cardiovascular Event Adjudication: New Algorithm Achieves Near-Human Accuracy Across Multiple Endpoints

By MedXY 04/05/2026

Researchers developed and validated ADAPT-CEC, an artificial intelligence algorithm that can adjudicate cardiovascular events across different trial definitions. A hybrid approach combining AI with selective human review achieved 95.6% accuracy and replicated major trial results.

AI Neurology news

Beyond Immersion: Why Combining Action Observation with Virtual Reality is a Game-Changer for Post-Stroke Hand Recovery

By MedXY 03/22/2026

A multicenter randomized controlled trial reveals that integrating action observation with virtual reality significantly improves paretic hand dexterity in stroke patients, with benefits persisting six months post-intervention, offering a superior multimodal approach to traditional neurorehabilitation.

AI Cardiology Clinical Updates news

Precision Prediction of Incident Heart Failure: The Clinical Integration of AI-Enabled Electrocardiography

By MedXY 03/09/2026

This review evaluates the breakthrough ECG2HF model, a publicly available AI tool that outperforms standard clinical scores in predicting 10-year heart failure risk using 12-lead ECG waveforms.

AI Clinical Updates Dermatology news

The Era of the ‘Virtual Biopsy’: Cross-Modal Imaging and the Noninvasive Identification of Skin Histology

By MedXY 03/04/2026

This review evaluates a pivotal study demonstrating that cross-modal imaging identifies skin histologic features with over 96% accuracy, offering a safe and effective noninvasive alternative to traditional biopsy for clinical decision-making.

AI news Ophthalmology

Breaking the Hardware Barrier: How Domain-Shift AI Enables Vendor-Agnostic 3D OCT Macular Disease Detection

By MedXY 02/27/2026

A multicenter study in JAMA Ophthalmology introduces a deep learning model using domain-shift technology to accurately detect macular diseases across different OCT hardware vendors, achieving high negative predictive value and establishing a robust triage system for diverse clinical settings.

AI news Radiology

AI-Supported Mammography Outperforms Standard Double Reading: Insights from the MASAI Trial

By MedXY 02/25/2026

The MASAI trial demonstrates that AI-supported mammography screening achieves higher sensitivity and non-inferior interval cancer rates compared to standard double reading, while maintaining specificity and significantly reducing radiologist workload.

AI Cardiology news

AI-Enabled Stethoscopes in Primary Care: Why Implementation Science Matters More Than Algorithm Accuracy

By MedXY 02/25/2026

The TRICORDER trial demonstrates that while AI stethoscopes are capable of detecting heart failure, atrial fibrillation, and valvular disease, their real-world implementation in UK primary care did not yield a statistically significant increase in new diagnoses over 12 months.

AI news Urology

Telesurgery Breaks the Distance Barrier: Landmark RCT Confirms Non-Inferiority to Local Robotic Urology

By MedXY 02/23/2026

A multicentre randomized controlled trial demonstrates that robotic telesurgery over distances up to 2800 km is non-inferior to local surgery for urological procedures, maintaining high success rates, low latency, and equivalent safety profiles.

AI news Ophthalmology

Human-AI Collaboration Enhances Clinical Reasoning in Ophthalmology but Risks Overconfidence and Automation Bias

By MedXY 02/22/2026

A crossover study involving 30 ophthalmologists and trainees reveals that while Claude-3.5-Sonnet collaboration improves diagnostic accuracy in complex cases, it also increases confidence in incorrect decisions and fails to reach the performance of the AI alone.

AI news Oncology Pathology & Lab Medicine

Precision Oncology Meets Artificial Intelligence: Navigating Ancestry-Associated Variability in Digital Pathology for EGFR Prediction

By MedXY 02/20/2026

This review evaluates the generalizability of AI pathology models in predicting EGFR mutations, highlighting significant performance variations across genetic ancestries and specimen types, and their role in clinical triage.

AI news

AI Assistant Achieves High Accuracy in Molecular-Based CNS Tumor Classification: A Multi-Institutional Validation

By MedXY 02/18/2026

This multi-institutional study validates Neuropath-AI, a deep-learning system that predicts CNS tumor types by inferring molecular features from histopathology slides. Achieving 80% top-1 accuracy in high-confidence samples, the model offers a scalable tool for enhancing diagnostic precision in neuro-oncology.

AI news Oncology

AI-Driven Detection of Extranodal Extension Outperforms Radiologists in Predicting Outcomes for HPV-Positive Oropharyngeal Cancer

By MedXY 02/11/2026

A single-center study demonstrates that an AI pipeline for CT-based lymph node segmentation and extranodal extension classification significantly improves prognostic accuracy for HPV-positive oropharyngeal cancer compared to traditional radiological assessment, identifying high-risk patients more effectively.

AI news Psychiatry

High Empathy, Low Accuracy: Can Generative AI Safely Navigate Alcohol Misuse Support?

By MedXY 02/02/2026

A longitudinal study published in NEJM AI evaluates seven generative AI chatbots for alcohol misuse support, finding that while they excel in empathy and non-judgmental language, they frequently provide low-quality or inaccurate medical information, highlighting critical safety concerns for clinical application.

AI Neurology news

AI-Driven Prognosis: EEGSurvNet Accurately Predicts Seizure Timing From Routine EEG Data

By MedXY 01/28/2026

Researchers developed EEGSurvNet, a deep survival model that analyzes routine EEG to predict seizure risk over two years. Outperforming clinical models, it achieved an AUROC of 0.80 at two months and showed high efficacy in patients without visible epileptiform discharges.

AI Cardiology news

AI-ECG Models for Heart Failure Screening Show High Accuracy in First-of-its-Kind Independent Comparison Study

By MedXY 01/26/2026

This independent validation study confirms that AI-enhanced ECG models effectively detect left ventricular systolic dysfunction across diverse populations, achieving AUROCs up to 0.93. However, significant barriers remain regarding model transparency and data sharing for clinical implementation.

AI Infectious Diseases news

AI-Driven Decision Support for Antibiotic Switching: Why Clinicians Value Caution Over Speed

By MedXY 01/15/2026

A randomized multimethod study reveals that while AI clinical decision support systems for antibiotic switching are well-received, their primary influence is reinforcing conservative prescribing. The study underscores that usability and clinical evidence outweigh the importance of AI explanations at the point of care.

AI Diabetes & Endocrinology news

Mobile Health Management Model Slashes Gestational Diabetes Incidence by Nearly 45% in High-Risk Pregnancies

By MedXY 01/10/2026

A randomized controlled trial demonstrates that an mHealth management model using the Better Pregnancy app significantly reduces GDM incidence, improves glycemic control, and enhances maternal self-efficacy among high-risk pregnant women, providing a scalable solution for modern obstetric care.

AI news Oncology Urology

Multimodal AI Outperforms Clinical Nomograms in Predicting Metastasis for Post-Prostatectomy Biochemical Recurrence

By MedXY 01/10/2026

A validated multimodal AI model using digital pathology and clinical data significantly improves risk stratification for prostate cancer patients with biochemical recurrence, identifying those who derive the greatest benefit from salvage hormone therapy.

AI news Oncology

AI-Derived Sarcopenia Metrics Predict Survival Benefit from Anti-EGFR Therapy in RAS Wild-Type Metastatic Colorectal Cancer

By MedXY 01/08/2026

A deep learning analysis of the PanaMa trial reveals that the benefit of adding panitumumab to maintenance therapy for RAS wild-type mCRC is significantly higher in patients with a high muscle-bone ratio, suggesting a new AI-driven approach to personalized oncology.